These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 31025540)

  • 1. Metformin and 4SC-202 synergistically promote intrinsic cell apoptosis by accelerating ΔNp63 ubiquitination and degradation in oral squamous cell carcinoma.
    He Y; Tai S; Deng M; Fan Z; Ping F; He L; Zhang C; Huang Y; Cheng B; Xia J
    Cancer Med; 2019 Jul; 8(7):3479-3490. PubMed ID: 31025540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interplay between ΔNp63 and miR-138-5p regulates growth, metastasis and stemness of oral squamous cell carcinoma.
    Zhuang Z; Xie N; Hu J; Yu P; Wang C; Hu X; Han X; Hou J; Huang H; Liu X
    Oncotarget; 2017 Mar; 8(13):21954-21973. PubMed ID: 28423539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin Combined with 4SC-202 Inhibited the Migration and Invasion of OSCC via STAT3/TWIST1.
    He Y; Fan Z; He L; Zhang C; Ping F; Deng M; Liu S; Wang Y; Cheng B; Xia J
    Onco Targets Ther; 2020; 13():11019-11029. PubMed ID: 33149616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased ΔNp63 expression is predictive of malignant transformation in oral epithelial dysplasia and poor prognosis in oral squamous cell carcinoma.
    Matsubara R; Kawano S; Kiyosue T; Goto Y; Hirano M; Jinno T; Toyoshima T; Kitamura R; Oobu K; Nakamura S
    Int J Oncol; 2011 Dec; 39(6):1391-9. PubMed ID: 21833468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor-β1 activates ΔNp63/c-Myc to promote oral squamous cell carcinoma.
    Hu L; Liu J; Li Z; Wang C; Nawshad A
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Oct; 122(4):460-482.e4. PubMed ID: 27567435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential roles of kallikrein-related peptidase 6 in malignant transformation and ΔNp63β-mediated epithelial-mesenchymal transition of oral squamous cell carcinoma.
    Kaneko N; Kawano S; Yasuda K; Hashiguchi Y; Sakamoto T; Matsubara R; Goto Y; Jinno T; Maruse Y; Morioka M; Hattori T; Tanaka S; Tanaka H; Kiyoshima T; Nakamura S
    Oral Oncol; 2017 Dec; 75():148-157. PubMed ID: 29224812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemistry of YAP and dNp63 and survival analysis of patients bearing precancerous lesion and oral squamous cell carcinoma.
    Ono S; Nakano K; Takabatake K; Kawai H; Nagatsuka H
    Int J Med Sci; 2019; 16(5):766-773. PubMed ID: 31217745
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro and in vivo anti-tumor effect of metformin as a novel therapeutic agent in human oral squamous cell carcinoma.
    Luo Q; Hu D; Hu S; Yan M; Sun Z; Chen F
    BMC Cancer; 2012 Nov; 12():517. PubMed ID: 23151022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin increases PDH and suppresses HIF-1α under hypoxic conditions and induces cell death in oral squamous cell carcinoma.
    Guimarães TA; Farias LC; Santos ES; de Carvalho Fraga CA; Orsini LA; de Freitas Teles L; Feltenberger JD; de Jesus SF; de Souza MG; Santos SH; de Paula AM; Gomez RS; Guimarães AL
    Oncotarget; 2016 Aug; 7(34):55057-55068. PubMed ID: 27474170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NEDD4L inhibits glycolysis and proliferation of cancer cells in oral squamous cell carcinoma by inducing ENO1 ubiquitination and degradation.
    Zhang G; Zhao X; Liu W
    Cancer Biol Ther; 2022 Dec; 23(1):243-253. PubMed ID: 35316145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
    Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
    Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-suppressive roles of ΔNp63β-miR-205 axis in epithelial-mesenchymal transition of oral squamous cell carcinoma via targeting ZEB1 and ZEB2.
    Hashiguchi Y; Kawano S; Goto Y; Yasuda K; Kaneko N; Sakamoto T; Matsubara R; Jinno T; Maruse Y; Tanaka H; Morioka M; Hattori T; Tanaka S; Kiyoshima T; Nakamura S
    J Cell Physiol; 2018 Oct; 233(10):6565-6577. PubMed ID: 29150940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of Oral Squamous Cell Carcinoma Proliferation Through Crosstalk Between SMAD7 and CYLD.
    Ge WL; Xu JF; Hu J
    Cell Physiol Biochem; 2016; 38(3):1209-17. PubMed ID: 26982322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblasts rescue oral squamous cancer cell from metformin-induced apoptosis via alleviating metabolic disbalance and inhibiting AMPK pathway.
    Zhang Z; Liang X; Fan Y; Gao Z; Bindoff LA; Costea DE; Li L
    Cell Cycle; 2019 May; 18(9):949-962. PubMed ID: 31014173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin inhibits mTOR and c-Myc by decreasing YAP protein expression in OSCC cells.
    Wang Y; Zhang Y; Feng X; Tian H; Fu X; Gu W; Wen Y
    Oncol Rep; 2021 Mar; 45(3):1249-1260. PubMed ID: 33650651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppressed mitochondrial respiration via NOX5-mediated redox imbalance contributes to the antitumor activity of anlotinib in oral squamous cell carcinoma.
    Huang Z; Su Q; Li W; Ren H; Huang H; Wang A
    J Genet Genomics; 2021 Jul; 48(7):582-594. PubMed ID: 34373220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible involvement of ΔNp63 downregulation in the invasion and metastasis of oral squamous cell carcinoma via induction of a mesenchymal phenotype.
    Goto Y; Kawano S; Matsubara R; Kiyosue T; Hirano M; Jinno T; Maruse Y; Toyoshima T; Kitamura R; Tanaka H; Oobu K; Nakamura S
    Clin Exp Metastasis; 2014 Mar; 31(3):293-306. PubMed ID: 24310252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genistein nanoformulation promotes selective apoptosis in oral squamous cell carcinoma through repression of 3PK-EZH2 signalling pathway.
    Dev A; Sardoiwala MN; Kushwaha AC; Karmakar S; Choudhury SR
    Phytomedicine; 2021 Jan; 80():153386. PubMed ID: 33113500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TAF1L promotes development of oral squamous cell carcinoma via decreasing autophagy-dependent apoptosis.
    Wang D; Qi H; Zhang H; Zhou W; Li Y; Li A; Liu Q; Wang Y
    Int J Biol Sci; 2020; 16(7):1180-1193. PubMed ID: 32174793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. As a Novel Tumor Suppressor, LHPP Promotes Apoptosis by Inhibiting the PI3K/AKT Signaling Pathway in Oral Squamous Cell Carcinoma.
    Liu S; Gao W; Lu Y; Zhou Q; Su R; Hasegawa T; Du J; Li M
    Int J Biol Sci; 2022; 18(2):491-506. PubMed ID: 35002505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.